SupremeToday Landscape Ad
Back
Next
Judicial Analysis Court Copy Headnote Facts Arguments Court observation
Listen Audio Icon Pause Audio Icon
judgment-img

2026 Supreme(Mad) 1874

IN THE HIGH COURT OF JUDICATURE AT MADRAS
C.V.KARTHIKEYAN, K.KUMARESH BABU, JJ.
M/s. J.R.K’s Research and Pharmaceuticals Pvt.Ltd. - Appellant
Vs.
M/s. Sanjeevi Pharma - Respondent
OSA(CAD) No. 1 of 2025 & C.M.P.No. 7 of 2025
Decided On : 06-03-2026

Advocates:
Advocate Appeared:
For the Appellant : Mr.M.S.Bharath
For the Respondent: Mr. R.Sathish Kumar

The court held that while both parties have registered trademarks, the evidence does not substantiate exclusive rights to either mark as both were deemed to not have been adopted bona fide.

Headnote:(A) Trademarks Act, 1999 - Sections 28, 29, and 30 - Appeal against dismissal of trademark infringement suit - Appellant claimed exclusive rights to '777 Oil', developed with NRDC, while respondent adopted 'SANJEEVI 777 OIL' - IPAB had previously annulled respondent's trademark due to lack of bona fide use - The learned single judge concluded neither party had exclusive rights, deeming both marks generic - Included issues around delay and bonafide use. (Paras 3, 4, 8, 19, 21)

(B) Appellate standard - The role of appellate court is to identify severe errors in the original judgment that may warrant interference. (Paras 17-21)

Facts of the case:
The plaintiff, a pharmaceutical entity, sought injunction against the respondent’s use of 'SANJEEVI 777 OIL', claiming trademark infringement based on prior use and registration of '777 Oil'. The learned Single Judge ruled in favor of the respondent, stating both brands could not claim exclusive rights.

Findings of Court:
The learned Single Judge indicated both trademarks '777 Oil' and 'SANJEEVI 777 OIL' were not exclusive to either party and that the evidence provided failed to establish distinctiveness for either mark.

Issues: The primacy of trademark rights between the appellant and the respondent, implications of prior judgments, and the bona fide nature of each party’s use of trademarks.

Ratio Decidendi: The court found that the appellant’s previous trademark registrations were valid; however, the evidence of bona fide use by both parties was insufficient to claim exclusivity, and the learned Single Judge's reliance on unproven electronic evidence was unwarranted.

Result: Appeal allowed, injunction granted to restrain the respondent from using '777 Oil' in any form.

Table of Content
1. background of trademark conflict and registrations. (Para 1 , 2 , 3 , 4 , 5)
2. arguments from both parties about trademark use. (Para 6 , 10 , 11 , 12 , 13 , 14)
3. court's observations on trademark rights and evidence. (Para 7 , 8 , 18 , 19 , 20)
4. hearing and judgment delivery by the court. (Para 9 , 16)
5. court's ruling on trademark infringement. (Para 15 , 17 , 21)

JUDGMENT :

(Judgment of the Court was delivered by K.Kumaresh Babu J.)

The present Original Side Appeal has been filed against the order dated 10.02.2023 passed by the learned single judge in C.S.No.651 of 2008, on the file of this court, whereby the learned single judge had dismissed the said suit.

2. The appellant company which was promoted by one Dr.J.R.Krishnamoorthy, formulated the Siddha medical oil for the treatment of Psoriasis. The said formulation was developed in association with the National Research Development Corporation (NRDC). The appellant company had marketed the said product under the brand name “777 Oil”, which was registered as the Trade Mark under the Trade Mark Registration No.1061418 in class 5, dated 20.11.2001.Its further claimed that the promoter of the appellant company had been using the mark “777 Oil” since the year of 1992, much prior to the registration.

3. When it came to the knowledge that the respondent company which operates in the similar line of trade, had adopted and registered an identical and a deceptively similar trade mark, namely “SANJEEVI 777 OIL”, registered as trade mark under the Trade Mark Registration No.1167605 ( Form TM-1) Class 5 dated 20.01.2003, the appellant had initiated appropriate proceedings. The appellant had approached the Intellectual Property Appellate Board (herein after referred to as IPAB) and challenged the respondent’s trade mark registration. The IPAB vide its order dated 16.08.2011, held that the respondent had no documents to substantiate their bonafide use of the trade mark. Especially no drug license with a list of drugs for which the license was issued was produced as required under the provisions of the Drugs and Cosmetics Act,1940. Therefore the IPAB vide its order supra had allowed the rectification and ordered for the removal of the respondent’s trade mark “SANJEEVI 777 OIL” from the Register of Trade Marks.

4. Aggreived by the same the respondent had approached this court challenging the IPAB order (supra) in W.P.No.20195 of 2011, which also came to be dismissed vide order dated 17.08.2011, thereby confirming the IPAB order and no further appeal was preferred by the respondent against the said order. The appellant company had further instituted a civil suit in C.S.No. 651 of 2008 before this court, inter alia, seeking permanent injunction against the respondent and restraining them from using the infringed trade mark. This court after hearing both sides had framed the following issues;

i) Whether the plaintiff is the proprietor of the trademark 777 OIL and whether they have the right to restrain the defendant from using 777 in their trademark ?

ii) Whether the expression 777 oil publici juris in Siddha medicine ?

iii)Whether the defendant had registered and used the trademark SANJEEVI 777 OIL since 1993 and whether they have the right to continue to use the trade mark SANJEEVI 777 OIL ?

iv) Whether the Suit is liable to be dismissed on the ground of delay and latches ?

v) Whether the defendant had infringed the trademark of the plaintiff?

vi) To what reliefs is the plaintiff entitled to vii) To what other reliefs ?

5. It was contended the appellant company had formulated the Siddha Medicinal Oil for the treatment of Psoriasis, which was developed in association with the NRDC. The product was named as “777 Oil” by its promotor Dr.J.K.Krishnamoorthy who was using the trademark since 1992. It was submitted that the NRDC and the Appellant company entered into a license agreement dated 19.11.1990, wherein the NRDC acted as the licensor, having acquired the full ownership of the KNOW

Click Here to Read the rest of this document
1
2
3
4
5
6
7
8
9
10
11
SupremeToday Portrait Ad
supreme today icon
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon Back to top